125 related articles for article (PubMed ID: 30040903)
1. Thienopyrimidine-Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer Cells.
Khan NS; Khan P; Ansari MF; Srivastava S; Hasan GM; Husain M; Hassan MI
Mol Pharm; 2018 Sep; 15(9):4173-4189. PubMed ID: 30040903
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
[TBL] [Abstract][Full Text] [Related]
3. Methoxychalcone induces cell-cycle arrest and apoptosis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathways.
Sun YW; Huang WJ; Hsiao CJ; Chen YC; Lu PH; Guh JH
Prostate; 2010 Sep; 70(12):1295-306. PubMed ID: 20623631
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
6. Millepachine, a novel chalcone, induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo.
Wu W; Ye H; Wan L; Han X; Wang G; Hu J; Tang M; Duan X; Fan Y; He S; Huang L; Pei H; Wang X; Li X; Xie C; Zhang R; Yuan Z; Mao Y; Wei Y; Chen L
Carcinogenesis; 2013 Jul; 34(7):1636-43. PubMed ID: 23471882
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of chalcone analogues containing a 4-oxoquinazolin-2-yl group as potential anti-tumor agents.
Han X; Peng B; Xiao BB; Sheng-Li Cao ; Yang CR; Wang WZ; Wang FC; Li HY; Yuan XL; Shi R; Liao J; Wang H; Li J; Xu X
Eur J Med Chem; 2019 Jan; 162():586-601. PubMed ID: 30472605
[TBL] [Abstract][Full Text] [Related]
8. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
9. Chalcones incorporated pyrazole ring inhibit proliferation, cell cycle progression, angiogenesis and induce apoptosis of MCF7 cell line.
Mohamed MF; Mohamed MS; Fathi MM; Shouman SA; Abdelhamid IA
Anticancer Agents Med Chem; 2014; 14(9):1282-92. PubMed ID: 25323033
[TBL] [Abstract][Full Text] [Related]
10. Novel Nitrogen-Based Chalcone Analogs Provoke Substantial Apoptosis in HER2-Positive Human Breast Cancer Cells via JNK and ERK1/ERK2 Signaling Pathways.
Rizeq B; Gupta I; Kheraldine H; Elkhalifa D; Al-Farsi HF; Moustafa AA; Khalil A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502529
[TBL] [Abstract][Full Text] [Related]
11. 3-Aminomethyl pyridine chalcone derivatives: Design, synthesis, DNA binding and cytotoxic studies.
Durgapal SD; Soni R; Umar S; Suresh B; Soman SS
Chem Biol Drug Des; 2018 Jul; 92(1):1279-1287. PubMed ID: 29575807
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
[TBL] [Abstract][Full Text] [Related]
13. Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile.
Mghwary AE; Gedawy EM; Kamal AM; Abuel-Maaty SM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):838-852. PubMed ID: 30919701
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of SL4 against breast cancer cells: induction of G
Wang LH; Jiang XR; Chen GL; Guo W; Zhang JY; Cui LJ; Li HH; Li M; Liu X; Yang JY; Wu CF
Sci Rep; 2016 Nov; 6():36486. PubMed ID: 27819344
[TBL] [Abstract][Full Text] [Related]
15. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Molecular Docking and Biological Activity Evaluation of Alkoxy Substituted Chalcone Derivatives: Potential Apoptosis Inducing Agent on MCF-7 Cells.
Khairul WM; Hashim F; Mohammed M; Shah NSMN; Johari SATT; Rahamathullah R; Daud AI; Ma NL
Anticancer Agents Med Chem; 2021; 21(13):1738-1750. PubMed ID: 33176667
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
[TBL] [Abstract][Full Text] [Related]
18. A small library of chalcones induce liver cancer cell death through Akt phosphorylation inhibition.
Sahin ID; Christodoulou MS; Guzelcan EA; Koyas A; Karaca C; Passarella D; Cetin-Atalay R
Sci Rep; 2020 Jul; 10(1):11814. PubMed ID: 32678233
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of two ruthenium(II)-DMSO-chalcone complexes: Comparison of cytotoxic, pro-apoptotic and antimetastatic potential.
Jovanovic KK; Gligorijevic N; Gaur R; Mishra L; Radulovic S
J BUON; 2016; 21(2):482-90. PubMed ID: 27273962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]